Mahkam Zanganeh - Aug 23, 2024 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Chief Executive Officer, Director
Signature
/s/ Mahkam Zanganeh
Stock symbol
SMMT
Transactions as of
Aug 23, 2024
Transactions value $
$0
Form type
4
Date filed
8/23/2024, 04:42 PM
Previous filing
Aug 13, 2024
Next filing
Sep 13, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SMMT Performance Stock Option (right to buy) Award +260K 260K Aug 23, 2024 Common Stock 260K $1.06 Direct F1, F2
transaction SMMT Performance Stock Option (right to buy) Award +100K 100K Aug 23, 2024 Common Stock 100K $1.29 Direct F2, F3
transaction SMMT Performance Stock Option (right to buy) Award +2.4M 2.4M Aug 23, 2024 Common Stock 2.4M $1.68 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These performance-based stock options vested on August 23, 2024, upon the attainment of the satisfaction of certain financial performance objectives. Note this does not include an additional 1,040,000 shares underlying options which were granted on June 28, 2022, that remain subject to the satisfaction of performance conditions.
F2 Not applicable.
F3 These performance-based stock options vested on August 23, 2024, upon the attainment of the satisfaction of certain financial performance objectives. Note this does not include an additional 400,000 shares underlying options which were granted on September 9, 2022 that remain subject to the satisfaction of performance conditions.
F4 These performance-based stock options vested on August 23, 2024, upon the attainment of the satisfaction of certain financial performance objectives. Note this does not include an additional 9,590,558 shares underlying options which were granted on October 13, 2023 that remain subject to the satisfaction of performance conditions.